FDA NDC Directory · JSON-LD · Markdown

ZILBRYSQ

NDC 50474-991 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namezilucoplan
Labeler / ManufacturerUCB, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA216834
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsZILUCOPLAN (40 mg/mL)
Marketing started20240103
Package count1

External sources

Source: openFDA. Public-domain (CC0).